Provided by Tiger Trade Technology Pte. Ltd.

vTv Therapeutics

33.89
+0.63501.91%
Post-market: 33.920.0300+0.09%19:30 EDT
Volume:18.00K
Turnover:610.39K
Market Cap:133.46M
PE:-32.10
High:34.66
Open:33.42
Low:32.87
Close:33.26
52wk High:44.00
52wk Low:15.27
Shares:3.94M
Float Shares:2.42M
Volume Ratio:0.41
T/O Rate:0.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0558
EPS(LYR):-3.2022
ROE:-15.80%
ROA:-10.14%
PB:6.26
PE(LYR):-10.58

Loading ...

Vtv Therapeutics Holds Annual Shareholder Meeting

Reuters
·
Jun 30

vTv Therapeutics grants 2,500 inducement stock options at $34.3 per share

Reuters
·
Jun 03

vTv Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 03

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jun 03

H.C. Wainwright Sticks to Their Buy Rating for vTv Therapeutics (VTVT)

TIPRANKS
·
May 27

vTv Therapeutics: Buy Rating Reiterated on Favorable Risk-Reward and Clinical Momentum; $67 Price Target Unchanged

TIPRANKS
·
May 15

Analysts Offer Insights on Healthcare Companies: vTv Therapeutics (VTVT), Waters (WAT) and Alpha Teknova (TKNO)

TIPRANKS
·
May 14

Analyst Maintains Buy on vTv Therapeutics, Reiterates Unchanged $49 Price Target Amid Progress of Cadisegliatin Program

TIPRANKS
·
May 14

vTv Therapeutics, Inc. : H.c. Wainwright Cuts Target Price to $45 From $47

THOMSON REUTERS
·
May 14

Analysts Offer Insights on Healthcare Companies: Damora Therapeutics (DMRA) and vTv Therapeutics (VTVT)

TIPRANKS
·
May 14

vTv Therapeutics Expands At-The-Market Share Program Capacity

TIPRANKS
·
May 14

vTv Therapeutics Inc - Increases Class a Common Stock Offered Under Atm Program to Full Amount - SEC Filing

THOMSON REUTERS
·
May 14

vTv Therapeutics boosts share capacity under at-the-market equity sales program

Reuters
·
May 14

vTv Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 14

vTv Therapeutics Q1 EPS $1.65 Beats $(0.10) Estimate, Sales $36.839M Beat $20.000M Estimate

Benzinga Earnings
·
May 14

vTv Therapeutics reports Q1 EPS $1.65, consensus 21c

TIPRANKS
·
May 14

vTv Therapeutics posts Q1 profit on license payment

Reuters
·
May 14

vTv Therapeutics Q1 FY26 swings to net income of $24.13 million; revenue $36.84 million

Reuters
·
May 14

vTv Therapeutics Q1 Operating Expenses USD 13.576 Million

THOMSON REUTERS
·
May 14

vTv Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview

Reuters
·
May 11